Celgene profit beats as psoriasis drug sales surge 12:02 AM Leave a Reply Celgene Corp, which is being bought by Bristol-Myers Squibb Co, reported a better-than-expected fourth-quarter profit on Thursday, driven mainly by higher sales of psoriasis drug Otezla. from Reuters: Health https://reut.rs/2sXBynO via IFTTT Tweet Share Share Share Share
0 comments: